Valuation : Ovation Science Inc.

Market Cap 11.53L 8L 7L 7L 6L 7.87Cr 11.56L 79.75L 30.94L 4.04Cr 31.3L 30.62L 13Cr P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 13.64L 10L 8L 8L 7L 9.31Cr 13.68L 94.32L 36.6L 4.78Cr 37.02L 36.21L 15Cr EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 -
1 day-79.67%
1 month-79.67%
3 months-78.57%
6 months-64.62%
Current year-74.58%
Current year 0.01
Extreme 0.007
0.08
1 year 0.01
Extreme 0.007
0.08
3 years 0.01
Extreme 0.007
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 30/10/2023
Chief Executive Officer 77 04/10/2017
Director TitleAgeSince
Director/Board Member 77 04/10/2017
Director/Board Member 63 04/10/2017
Director/Board Member 86 02/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-79.67%-.--% - - 8L
+1.43%-1.18%-5.07%-5.39% 24TCr
-2.58%-7.20%+11.96% - 4.57TCr
-2.96%-14.63%+81.15% - 1.1TCr
+0.61%-8.52%+41.59%-42.15% 882.18Cr
+0.56%-4.85%+20.72%+7.18% 656.8Cr
+2.10%+5.35%-17.99%-19.93% 647.14Cr
+2.35%-0.93%+1.94%-17.08% 373.71Cr
+0.51%+2.75%-22.93%-44.31% 367.84Cr
+0.36%-2.03%-4.73%-41.30% 285.96Cr
Average -7.73%-3.30%+11.85%-23.28% 3.63TCr
Weighted average by Cap. +0.69%-2.55%+1.62%-7.70%

Financials

2024 2025
Net sales 1L 81.83T 70.42T 66.25T 60.52T 77.26L 1L 8L 3L 39.64L 3L 3L 1.28Cr 67.89T 49.07T 42.22T 39.73T 36.29T 46.33L 68.07T 5L 2L 23.77L 2L 2L 76.57L
Net income -5L -3L -3L -3L -2L -3.11Cr -5L -31.55L -12.24L -1.6Cr -12.38L -12.11L -5.15Cr -6L -5L -4L -4L -3L -4.31Cr -6L -43.65L -16.94L -2.21Cr -17.13L -16.76L -7.12Cr
Net Debt 3L 2L 2L 2L 1L 1.81Cr 3L 18.34L 7L 92.84L 7L 7L 2.99Cr 2L 2L 1L 1L 1L 1.44Cr 2L 14.57L 6L 73.8L 6L 6L 2.38Cr
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-